0001572426-16-000158.txt : 20160222
0001572426-16-000158.hdr.sgml : 20160222
20160222194342
ACCESSION NUMBER: 0001572426-16-000158
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160218
FILED AS OF DATE: 20160222
DATE AS OF CHANGE: 20160222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK
STREET 2: RAHAN ROAD
CITY: TULLAMORE , CO. OFFALY
STATE: L2
ZIP: R35 FR98
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK
STREET 2: RAHAN ROAD
CITY: TULLAMORE , CO. OFFALY
STATE: L2
ZIP: R35 FR98
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lismore Damian T.
CENTRAL INDEX KEY: 0001560864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 161446556
MAIL ADDRESS:
STREET 1: 12270 WILKINS AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20852
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-02-18
0001618561
Nexvet Biopharma plc
NVET
0001560864
Lismore Damian T.
C/O NEXVET BIOPHARMA PLC
UNIT 5, SRAGH TECHNOLOGY PARK, RAHAN RD
TULLAMORE
L2
R35 FR98
IRELAND
0
1
0
0
Chief Financial Officer
Ordinary Shares
2016-02-18
4
P
0
5000
3.2199
A
18724
I
Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C>
Ordinary Shares
16000
D
Ordinary Shares
14160
I
By Spouse
Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.19 to $3.29, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The reporting person and his spouse share voting and dispositive power with respect to these reported securities.
/s/ Damian Lismore by Geraldine Farrell, Attorney-in-Fact
2016-02-22